MedPath

Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity

Phase 4
Conditions
Dry Eye
Interventions
Device: Intense Pulse Light Energy delivery (IPL)
Registration Number
NCT02992535
Lead Sponsor
Carones Ophthalmology Center
Brief Summary

Evaluate changes in tear film osmolarity and other DED signs/symptoms following treatment with IPL.

Detailed Description

Prospective study design among subjects with MGD and qualifying for IPL therapy.

Study testing done at baseline visit when subjects are scheduled for IPL therapy. Measurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4).

Subjects willing to come for follow up visits as scheduled and may not have instilled any artificial tears 2 hours prior to study measurements.

No history of ocular infection or corneal degeneration/dystrophy No history of corneal refractive surgery and/or change in ocular medications in the last 2 months

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Dry eye
  • MGD
Exclusion Criteria
  • No history of ocular infection or corneal degeneration/dystrophy
  • No history of corneal refractive surgery
  • No change in ocular medications in the last 2 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Single armIntense Pulse Light Energy delivery (IPL)Intense pulse light therapy (E-Schwin)
Primary Outcome Measures
NameTimeMethod
Tear film osmolarity changeMeasurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath